49Indexed trials
Market Rank #42 · Evidence Tier A
Colombia
Neuroscience Intelligence
Colombia neuroscience intelligence: 49 indexed trials, 21 institutions, research score 29.09.
14Recruiting
21Research institutions
29.1Research score
Evidence profile
25Sponsors
14Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 29.1 · Data confidence 100.00 · Evidence 29.1
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
parkinsons13trials
schizophrenia6trials
other_neurology5trials
pain_neuropathy4trials
epilepsy4trials
stroke3trials
alzheimers3trials
depression3trials
multiple_sclerosis2trials
autism2trials
Leading indexed sponsors
Merck Sharp & Dohme LLC12trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.5trials
Washington University School of Medicine3trials
Sumitomo Pharma America, Inc.3trials
Boehringer Ingelheim2trials
Forest Laboratories2trials
Pfizer2trials
Hoffmann-La Roche2trials
Novartis Pharmaceuticals2trials
Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul1trials